Your browser doesn't support javascript.
loading
Precision therapy for neuromyelitis optica spectrum disorder: A retrospective analysis of the use of class-switched memory B-cells for individualised rituximab dosing schedules.
Trewin, Benjamin P; Adelstein, Stephen; Spies, Judith M; Beadnall, Heidi N; Barton, Joshua; Ho, Nicholas; Gallagher, Kerri J; Barnett, Michael H.
Afiliação
  • Trewin BP; Neurology, Royal Prince Alfred Hospital (RPAH), Australia; Brain & Mind Centre, University of Sydney (USyd), Australia.
  • Adelstein S; Immunology, RPAH, Australia; Faculty of Medicine & Health, USyd, Australia.
  • Spies JM; Neurology, Royal Prince Alfred Hospital (RPAH), Australia; Brain & Mind Centre, University of Sydney (USyd), Australia; Faculty of Medicine & Health, USyd, Australia.
  • Beadnall HN; Neurology, Royal Prince Alfred Hospital (RPAH), Australia; Brain & Mind Centre, University of Sydney (USyd), Australia.
  • Barton J; Brain & Mind Centre, University of Sydney (USyd), Australia.
  • Ho N; Brain & Mind Centre, University of Sydney (USyd), Australia.
  • Gallagher KJ; Immunology, RPAH, Australia.
  • Barnett MH; Neurology, Royal Prince Alfred Hospital (RPAH), Australia; Brain & Mind Centre, University of Sydney (USyd), Australia; Faculty of Medicine & Health, USyd, Australia. Electronic address: michael.barnett@sydney.edu.au.
Mult Scler Relat Disord ; 43: 102175, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32417664

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuromielite Óptica Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuromielite Óptica Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article